SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Directors' Interests

5 Jul 2012 16:16

RNS Number : 0480H
Accsys Technologies PLC
05 July 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

5 July 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Directors' Interests

 

The Company announces that in connection with employee remuneration and incentivisation arrangements and in respect of the period from 1 July 2011 to 30 June 2012, following recommendation from the nomination and remuneration committee of the Company, the Board has resolved to issue Ordinary Shares to an Employee Benefit Trust, the beneficiaries of which include executive Directors.

 

Such Ordinary Shares shall vest if the employees, including the executive Directors, remain in employment with the Company to the vesting date, being 1 July 2013 (subject to certain other provisions including good-leaver, take-over and committee discretion provisions).

 

A total of 3,926,666 Ordinary Shares will be issued to the Employee Benefit Trust, of which 2,166,666 relate to the executive Directors as set out below:

 

Name Number Number of Ordinary Shares

Paul Clegg 1,500,000

Hans Pauli 666,666

 

All Ordinary Shares will be issued pending admission to trading on AIM and Euronext which is expected to take place on 6 July 2012.

 

The issued share capital of the Company following admission will be 407,943,308.

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accoya®, Tricoya®, the Trimarque Device and the Elements logo are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASXSEFLAEFF
Date   Source Headline
13th Dec 20067:01 amRNSInterim Results
23rd Nov 20067:00 amRNSNotifiable Interest
14th Nov 20067:01 amRNSHolding(s) in Company
2nd Nov 20067:01 amRNSPlacing raises EUR9.8million
28th Sep 20067:01 amRNSLicence Agreement
25th Sep 20067:00 amRNSHolding(s) in Company
12th Sep 20067:01 amRNSTitan Wood NZ agreement
2nd Aug 20067:00 amRNSAccoya-exclusive agreement
26th Jul 20067:00 amRNSHolding(s) in Company
14th Jun 20067:00 amRNSPRELIMINARY RESULTS
20th Mar 20067:01 amRNSBSW Timber Endorsement
2nd Mar 20067:01 amRNSUK launch of Accoya with BSW
19th Dec 20057:00 amRNSOption Agreement
16th Dec 20053:54 pmRNSInterim Results
2nd Dec 200510:03 amRNSIssue of Equity
3rd Nov 20057:00 amRNSAkzo Nobel Endorsement
26th Oct 20058:05 amRNSAIM Admission

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.